• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Migration or Expulsion of Device (1395); Biocompatibility (2886)
Patient Problems Headache (1880); Complete Heart Block (2627)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
The article "feasibility of transcatheter closure of secundum atrial septal defect in low weight infants under 2-year-old from a three-year retrospective cohort study" was reviewed.This article was a retrospective study to evaluate the feasibility of interventional treatment of atrial septal defects (asd) in low weight infants under 2-year-old.From january 2011 to december 2016, 793 secundum asd patients were divided into two groups: 665 were above 2-year-old and 128 were under 2-year-old.Transcatheter occluders from different manufacturers are associated with the study including beijing huayi shengjie asd occluder, lifetech scientific asd occluder, boat fit asd occluder, and abbott amplatzer septal occluder.There was no allegation of malfunction against the abbott device.The primary author is chunhui cao, md, department of cardiology, shenzhen hospital, southern medical university, guangdong, china.The corresponding author is zhiwei zhang, with corresponding email: drzhangzw@sohu.Com.
 
Manufacturer Narrative
As reported in a research article, patients implanted with an amplatzer septal occluder included embolization of the device, headache, residual shunt, and arrythmia.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10284991
MDR Text Key200813794
Report Number2135147-2020-00319
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 08/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-